Specialist radiotherapy equipment at the Northern Ireland Cancer Centre 'increasing chances to cure some patients'.
According to statistics, stereotactic radiotherapy has improved the control rate of early-stage lung cancer from 50% using standard radiotherapy to 85%.Specialist radiotherapy equipment at the Northern Ireland Cancer Centre has increased the chances of curing the disease in some patients, according to its clinical director for oncology.Prof Gerry Hanna said this targets the tumour with more precision than conventional radiotherapy.
"This allows us to increase the chances of curing that cancer because the dose that we use is much higher and safer than what was previously used." SABR treatment is non-invasive for patients with localised and secondary tumours and especially for those with lung cancer who cannot undergo surgery.Jennings Moffett, 79, who is attending the cancer centre, said the treatment has "kept him alive".He said the diagnosis scared him but attending the cancer centre has given him peace of mind.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Breast cancer mortality in 500 000 women with early invasive breast cancer in England, 1993-2015: population based observational cohort studyObjectives To describe long term breast cancer mortality among women with a diagnosis of breast cancer in the past and estimate absolute breast cancer mortality risks for groups of patients with a recent diagnosis. Design Population based observational cohort study. Setting Routinely collected data from the National Cancer Registration and Analysis Service. Participants All 512 447 women registered with early invasive breast cancer (involving only breast and possibly axillary nodes) in England during January 1993 to December 2015, with follow-up to December 2020. Main outcome measures Annual breast cancer mortality rates and cumulative risks by time since diagnosis, calendar period of diagnosis, and nine characteristics of patients and tumours. Results For women with a diagnosis made within each of the calendar periods 1993-99, 2000-04, 2005-09, and 2010-15, the crude annual breast cancer mortality rate was highest during the five years after diagnosis and then declined. For any given time since diagnosis, crude annual breast cancer mortality rates and risks decreased with increasing calendar period. Crude five year breast cancer mortality risk was 14.4% (95% confidence interval 14.2% to 14.6%) for women with a diagnosis made during 1993-99 and 4.9% (4.8% to 5.0%) for women with a diagnosis made during 2010-15. Adjusted annual breast cancer mortality rates also decreased with increasing calendar period in nearly every patient group, by a factor of about three in oestrogen receptor positive disease and about two in oestrogen receptor negative disease. Considering just the women with a diagnosis made during 2010-15, cumulative five year breast cancer mortality risk varied substantially between women with different characteristics: it was |3% for 62.8% (96 085/153 006) of women but ≥20% for 4.6% (6962/153 006) of women. Conclusions These five year breast cancer mortality risks for patients with a recent diagnosis may be used to estimate breast cancer mortality risks fo
Read more »
Victoria Centre open amid major city centre police incidentDozens of emergency service vehicles remain at the scene
Read more »
The Cube and Doctor Who star diagnosed with prostate cancerActor Colin McFarlane, who is the voice of The Cube and has starred in Doctor Who, has shared that he has been diagnosed with prostate cancer, nine months after his brother was diagnosed
Read more »
Doctor Who and Batman star reveals prostate cancer diagnosisA DOCTOR Who and Batman star has revealed his prostate cancer diagnosis – nine months after his sibling battled the disease. Colin McFarlane has revealed his shock diagnosis following a posit…
Read more »
'Most common' cancer symptom that gets worse at night, according to doctorThe medical expert recommends getting checked out if you've been experiencing symptoms for more than three weeks.
Read more »